Antibody Responses to Vaccination among South African HIV-Exposed and Unexposed Uninfected Infants during the First 2 Years of Life

Author:

Reikie Brian A.12,Naidoo Shalena3,Ruck Candice E.1,Slogrove Amy L.14,de Beer Corena5,la Grange Heleen5,Adams Rozanne C. M.3,Ho Kevin1,Smolen Kinga1,Speert David P.1,Cotton Mark F.4,Preiser Wolfgang5,Esser Monika3,Kollmann Tobias R.1

Affiliation:

1. Division of Infectious & Immunological Diseases and Centre for Understanding and Preventing Infections in Children, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada

2. Faculty of Medicine, Leaders in Medicine Program, University of Calgary, Alberta, Canada

3. Immunology Unit, Division of Medical Microbiology, Department of Pathology, NHLS and Stellenbosch University, Cape Town, South Africa

4. Department of Paediatrics and Child Health, Tygerberg Children's Hospital and Stellenbosch University, Cape Town, South Africa

5. Division of Medical Virology, Department of Pathology, NHLS and Stellenbosch University, Cape Town, South Africa

Abstract

ABSTRACT HIV-exposed but uninfected (HEU) infants born to HIV-infected mothers from areas in the world with a high burden of infectious disease suffer higher infectious morbidity and mortality than their HIV unexposed uninfected (HUU) peers. Vaccination provides protection from infection. The possibility exists that altered response to vaccination contributes to the higher rate of infection in HEU than in HUU infants. While short-term, cross-sectional studies support this notion, it is unclear whether or not HEU infants develop long-term protective immune responses following the WHO extended program on immunization (EPI). Vaccine-specific antibody responses were compared between HEU and HUU infants from 2 weeks until 2 years of age in a longitudinal South African cohort. Total IgG and antibodies specific for Bordetella pertussis , Haemophilus influenzae type b (Hib), tetanus toxoid, hepatitis B virus (HepB), and measles virus were measured at multiple time points throughout the first 2 years of life. Prevaccine antibodies (maternal antibodies passively acquired) specific for tetanus were lower in HEU than in HUU infants, while prevaccine antibodies to HepB were higher in HEU than in HUU infants. Both groups responded similarly to tetanus, Hib, and HepB vaccination. HEU demonstrated stronger pertussis vaccine responses, developing protective titers 1 year earlier than HUU patients, and maintained higher anti-tetanus titers at 24 months of age. Vaccine-induced antibodies to measles virus were similar in both groups at all time points. Our results suggest that the current EPI vaccination program as practiced in South Africa leads to the development of vaccine-specific antibody responses that are equivalent in HEU and HUU infants. However, our data also suggest that a large fraction of both HEU and HUU South African infants have antibody titers for several infectious threats that remain below the level of protection for much of their first 2 years of life.

Publisher

American Society for Microbiology

Subject

Microbiology (medical),Clinical Biochemistry,Immunology,Immunology and Allergy

Reference34 articles.

1. Neonatal immunization: where do we stand?;Wood N;Curr. Opin. Infect. Dis.,2011

2. Global, regional, and national causes of child mortality in 2008: a systematic analysis

3. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data;Lopez AD;Lancet,2006

4. WHO. 2009. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report. WHO, Geneva, Switzerland.

5. UNAIDS. 2011. How to get to zero: faster. Smarter. Better. UNAIDS World AIDS Day Report 2011. Joint United Nations Programme on HIV/AIDS, Geneva, Switzerland.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3